
WHO approves first African-manufactured malaria drug
12 November 2023 The Independent The combination therapy for seasonal malaria chemoprevention is made in Kenya Kampala, Uganda | THE INDEPENDENT | A leading Kenya-based pharmaceutical manufacturer, Universal Corporation Ltd (UCL), has become the first African manufacturer to gain WHO prequalification for their sulfadoxine-pyrimethamine + amodiaquine